CRP and chronic kidney disease: The pooled analysis showed that paricalcitol supplementation in CKD patients significantly reduces the level of CRP compared to the control group [WMD = -2.55 mg/L, 95% CI (-4.99 to -0.11), I2 = 66.3%] (Fig. 2).